Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal women. It irreversibly binds to the active site of the enzyme resulting in permanent inhibition.
For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.